COVID-19 vaccination in Canada
Older versions of this report are available on the archived reports page .
Vaccination coverage
This page provides information on the number and percentage of people that have received a COVID-19 vaccine in Canada by province or territory, vaccination status, sex, age group, and vaccine series.
We update this information every 4 weeks on Fridays at noon Eastern Time with data up to and including the previous Sunday.
This report was last updated on with data up to and including MMM DD, YYYY .
On this page
Key updates
Total population
( )
5 years and older
( )
5 to 11 years
( )
Total population
( )
5 years and older
( )
5 to 11 years
( )
Total population
( )
12 years and older
( )
Total population
( )
70 years and older
( )
About COVID-19 vaccines and vaccination
Vaccination programs, primary series and booster doses
Vaccination programs
- COVID-19 vaccination began in Canada on December 14, 2020.
-
7 COVID-19 vaccines are currently approved for use in Canada.
- The COVISHIELD version of the AstraZeneca vaccine is no longer used in Canada as the interim order for its use expired on September 16, 2021.
- The National Advisory Committee on Immunization’s (NACI) recommendations on the use of COVID-19 vaccines can be found in the latest NACI statements .
- People 6 months and older without contraindications to the vaccine are currently eligible for COVID-19 vaccination.
Primary series
Primary series of vaccination refers to the number of doses of a COVID-19 vaccine that a person should receive to obtain initial protection. On this page, people are considered to have completed the primary series (referred as “fully vaccinated” in previous reports) once they have received all required doses. The number of doses depends on the specific vaccine product.
2-dose vaccines
- Pfizer-BioNTech Comirnaty® (two formulations, one for those aged 12 and older and another one for those aged 5 to 11 years)
- Moderna Spikevax® (three formulations, i.e., one for those aged 6 months to 5 years, one for those aged 6 to 11 years, and one for those aged 12 and older)
- AstraZeneca Vaxzevria® (18 and older)
- Novavax Nuvaxovid® (18 and older)
- Medicago Covifenz® (18 to 64)
For all 2-dose vaccines:
- People who have received only 1 dose are considered partially vaccinated.
- People who have received both doses are considered to have completed their primary vaccine series (referred to as "fully vaccinated" in previous reports).
- Moderately to severely immunocompromised people who have received both doses and an additional dose of an mRNA vaccine are considered to have completed their primary vaccine series.
1-dose vaccine
- Janssen (18 and older)
For 1-dose vaccines:
- People who have received only 1 dose are considered to have completed their primary vaccine series.
- Moderately to severely immunocompromised people who have received 1 dose and an additional dose of an mRNA vaccine are considered to have completed their primary vaccine series.
Booster doses
A booster dose received after the primary series restores or improves protection against COVID-19.
NACI recommends a booster dose of an mRNA vaccine or Novavax Nuvaxovid® at least 6 months after the primary series is completed for members of the following populations:
-
A booster
should
be offered to:
- adults 18 and older
- adults living in long-term care homes for seniors or other congregate living settings that provide care for seniors
- people who completed their series with only viral vector vaccines (AstraZeneca Vaxzevria/COVISHIELD or Janssen COVID-19 vaccines)
- adults in or from First Nations, Inuit, and Métis communities
- all frontline health care workers who have direct in-person contact with patients
-
adolescents 12 to 17:
- with an underlying medical condition or at high risk of severe illness from COVID-19 (including those who are immunocompromised and who received a 3-dose primary series)
- who are residents of congregate living settings (such as shelters, group homes, quarters for migrant workers, correctional facilities)
- who belong to racialized and/or marginalized communities disproportionately affected by COVID-19
-
A booster
may
be offered to:
- adolescents 12 to 17
NACI recommends that jurisdictions prepare for the rapid deployment of a second COVID-19 vaccine booster dose program prioritizing certain populations.
Local information
For local information on doses administered, please see your province’s or territory’s COVID-19 vaccination website .
National vaccination coverage Access and download the national vaccination coverage data over time in .csv format
Vaccination coverage is high in Canada, with [prop_atleast1dose] of the population vaccinated with at least one dose. In the last 4 weeks, many people received vaccines:
- [numweekdelta_atleast1dose] received their first dose
- [numweekdelta_fully] completed their primary series
- [numweekdelta_additional] people 12 and older received 1 additional dose
- [numweekdelta_2nd_additional] people 70 and older received a second additional dose
Figure 1. of who have received of a COVID-19 vaccine in Canada by jurisdiction, MMM DD, YYYY
Hover over or select a portion of the map to see the cumulative number or percent of people vaccinated in Canada and each jurisdiction over time.
For local vaccination coverage data, please see your province’s or territory’s COVID-19 vaccination website .
* Data on "Primary series completed and 2 additional doses" were not available for Alberta, New Brunswick and Nunavut.
Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status and jurisdiction, MMM DD, YYYY
Figure 1: Text description
Week ending | Jurisdiction | Age group | Cumulative number of people who have received at least 1 dose | Cumulative number of people who have completed the primary series | Cumulative number of people who have completed the primary series and received at least 1 additional dose | Cumulative number of people who have completed the primary series and received 2 additional doses | Cumulative percent of people who have received at least 1 dose | Cumulative percent of people who have completed the primary series | Cumulative percent of people who have completed the primary series and received at least 1 additional dose | Cumulative percent of people who have completed the primary series and received 2 additional doses |
---|
Figure 2. of who have received a COVID-19 vaccine in by vaccination status and report week, MMM DD, YYYY
Hover over or select a portion of the line graph to see the cumulative number or percentages of people vaccinated by vaccination status and report week.
* The reporting frequency changed from every week to every 2 weeks after April 10, 2022 and every 4 weeks after May 22, 2022.
** Data on "Primary series completed and 2 additional doses" were not available for Alberta, New Brunswick and Nunavut.
Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status and jurisdiction, MMM DD, YYYY
Figure 2: Text description
Week ending | Jurisdiction | Age group | Cumulative number of people who have received at least 1 dose | Cumulative number of people who have completed the primary series | Cumulative number of people who have completed the primary series and received at least 1 additional dose | Cumulative number of people who have completed the primary series and received 2 additional doses | Cumulative percent of people who have received at least 1 dose | Cumulative percent of people who have completed the primary series | Cumulative percent of people who have completed the primary series and received at least 1 additional dose | Cumulative percent of people who have completed the primary series and received 2 additional doses |
---|
Figure 3. Cumulative percent of who have received a COVID-19 vaccine in Canada by vaccination status and province or territory, as of MMM DD, YYYY
Notes
Cumulative number and percent of people who have received of a COVID-19 vaccine in Canada by vaccination status and province or territory, as of MMM DD, YYYY
Figure 3: Text description
Week ending | Jurisdiction | Age group | Cumulative number of people who have received at least 1 dose | Cumulative number of people having completed the primary series and received no additional dose | Cumulative number of people having completed the primary series and received only 1 additional dose | Cumulative number of people having completed the primary series and received 2 additional doses | Cumulative percent of people who have received at least 1 dose | Cumulative percent of people having completed the primary series and received no additional dose | Cumulative percent of people having completed the primary series and received only 1 additional dose | Cumulative percent of people having completed the primary series and received 2 additional doses |
---|
Vaccination coverage by age, sex, and province or territory
- A greater percentage of females than males have received a COVID-19 vaccine.
- Vaccination coverage is highest in adults aged 60 and older , with more than {{proptotal_fully%}} having completed their primary series. More than {{proptotal_additional%}} have completed their primary series and received at least 1 additional dose.
For more information on the vaccination status listed in Table 1 and 2, please refer to their definitions .
Table 1. Cumulative number and percent of people in Canada who have received a COVID-19 vaccine by sex and vaccination status, MMM DD, YYYY
Sex | At least 1 dose | Primary series completed | Primary series completed and at least 1 additional dose | Primary series completed and 2 additional doses |
---|---|---|---|---|
Females | ( ) | ( ) | ( ) | ( ) |
Males | ( ) | ( ) | ( ) | ( ) |
Table 2. Cumulative number and percent of people in Canada who have received a COVID-19 vaccine by age group and vaccination status, MMM DD, YYYY
Age group (years) | At least 1 dose | Primary series completed | Primary series completed and at least 1 additional dose | Primary series completed and 2 additional doses |
---|
Notes
Figure 4. of people who have received of a COVID-19 vaccine in by age group and sex, MMM DD, YYYY Access and download the vaccination coverage by age, sex, and province/territory data over time in .csv format
Hover over or select a bar to see the cumulative number or percent of people vaccinated so far.
Figure 4: Text description
Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status, age group, sex, and jurisdiction, MMM DD, YYYY
Jurisdiction | Sex | Age group | Cumulative number of people who have received at least 1 dose | Cumulative number of people who have completed the primary series | Cumulative number of people who have completed the primary series and received at least 1 additional dose | Cumulative number of people who have completed the primary series and received 2 additional doses | Cumulative percent of people who have received at least 1 dose | Cumulative percent of people who have completed the primary series | Cumulative percent of people who have completed the primary series and received at least 1 additional dose | Cumulative percent of people who have completed the primary series and received 2 additional doses |
---|
Figure 5. of who have received of a COVID-19 vaccine in by age group and report week, MMM DD, YYYY Access and download the vaccination coverage by age, sex, and province/territory data over time in .csv format
Hover over or select a portion of the line graph to see the cumulative number or percent of people vaccinated by age group and report week. Click on a legend element to add or remove the corresponding lines from the graph.
* The reporting frequency changed from every week to every 2 weeks after April 10, 2022 and every 4 weeks after May 22, 2022.
Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status, age group, sex, and jurisdiction, MMM DD, YYYY
Figure 5: Text description
Jurisdiction | Sex | Age group | Cumulative number of people who have received at least 1 dose | Cumulative number of people who have completed the primary series | Cumulative number of people who have completed the primary series and received at least 1 additional dose | Cumulative number of people who have completed the primary series and received 2 additional doses | Cumulative percent of people who have received at least 1 dose | Cumulative percent of people who have completed the primary series | Cumulative percent of people who have completed the primary series and received at least 1 additional dose | Cumulative percent of people who have completed the primary series and received 2 additional doses |
---|
Vaccination coverage by vaccine series
7 COVID-19 vaccines have been approved for use in Canada.
People in Canada have received a variety of vaccine series, the most common of which is a series containing only the Pfizer-BioNTech Comirnaty vaccine.
For more information on the vaccine series listed in Table 3, please refer to their definitions .
Table 3. Cumulative percent and number of people who have received a COVID-19 vaccine in by vaccine series and vaccination status, MMM DD, YYYY Access and download the vaccination coverage by age, sex, and province/territory data in .csv format
Primary series schedule | Vaccine included in the primary vaccine series | At least 1 dose | Primary series completed |
---|
Figure 6. of people who have received additional doses of a COVID-19 vaccine in by vaccine product and vaccination status, MMM DD, YYYY Access and download the cumulative number and percent of people who have received a COVID-19 vaccine by vaccine product, vaccination status, jurisdiction, and report week data in .csv format
Hover over a portion of the bar graph to see the cumulative number or percent of people vaccinated by vaccine product and vaccination status.
Figure 6: Text description
Cumulative number and percent of people who have received a COVID-19 vaccine by vaccine product, vaccination status, jurisdiction, and report week, MMM DD, YYYY
Week ending | Jurisdiction | Vaccine | Cumulative number of people who have completed the primary series and received at least 1 additional dose | Cumulative number of people who have completed the primary series and received 2 additional doses | Cumulative percent of people who have completed the primary series and received at least 1 additional dose | Cumulative percent of people who have completed the primary series and received 2 additional doses |
---|
Acknowledgements
This report would not be possible without the collaboration of provincial and territorial public health partners as well as members of the Pan-Canadian Public Health Network’s Canadian Immunization Registries and Coverage Network (CIRC). We would like to thank everyone taking part in the COVID-19 vaccination rollout in Canada.
Suggested citation
Public Health Agency of Canada. Canadian COVID-19 vaccination coverage report. Ottawa: Public Health Agency of Canada; January 22, 2021 . https://health-infobase.canada.ca/covid-19/vaccination-coverage/
Related links
- Vaccines for COVID-19
- COVID-19: Effectiveness and benefits of vaccination
- COVID-19 daily epidemiology update: Cases following vaccination
- COVID-19 vaccine uptake and intent: Canadian Community Health Survey (CCHS) insight
- COVID-19 Vaccination Coverage Survey (CVCS)
- COVID-19 in Canada
- Vaccine distribution
- Reported side effects following COVID-19 vaccination in Canada
- The facts about COVID-19 vaccines
- Publications: Vaccines and immunization
- Vaccines for children
- Ask the experts video series: COVID-19 vaccines questions
For health professionals
- COVID-19 information for health professionals
- National Advisory Committee on Immunization (NACI)
- COVID-19 daily epidemiology update
Provincial, territorial and other federal COVID-19 vaccination webpages
- British Columbia
- Alberta
- Saskatchewan
- Manitoba
- Ontario
- Quebec
- New Brunswick
- Nova Scotia
- Prince Edward Island
- Newfoundland and Labrador
- Yukon
- Northwest Territories
- Nunavut
- Indigenous Services Canada
- Correctional Service Canada
- Date modified: